DMAC
DiaMedica Therapeutics Inc
8.20$
-1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.8% | 56.6% | 47.6% | 84.1% | 84.8% | 55.8% | 34.6% | 43.2% | 64.1% | 90.1% | 94.5% | 93.6% | 99.0% | 82.9% | 98.0% | 97.6% | 99.4% | 99.8% | 98.4% | 99.1% | 96.3% | 98.8% | |
| 3.5% | 48.8% | 38.1% | 80.7% | 82.3% | 50.5% | 31.3% | 41.9% | 60.8% | 86.8% | 72.4% | 74.5% | 92.7% | 75.1% | 91.7% | 42.9% | 26.4% | 10.3% | 13.7% | 8.4% | 6.5% | 25.5% | |
| 3.5% | 48.8% | 38.1% | 80.7% | 82.3% | 50.5% | 31.3% | 41.9% | 60.8% | 86.8% | 72.4% | 74.5% | 92.7% | 75.1% | 91.7% | 87.0% | 97.9% | 99.0% | 97.4% | 97.7% | 95.3% | 97.6% | |
| 9.2% | 5.4% | 8.1% | 2.2% | 1.0% | 3.8% | 2.4% | 0.8% | 0.5% | 0.5% | 3.0% | 4.3% | 2.8% | 4.4% | 3.5% | 9.1% | 1.2% | 0.3% | 0.2% | 0.7% | 0.5% | 0.4% | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.0% | 0.0% | 0.2% | – | – | – | – | |
| – | – | – | – | – | – | 0.1% | 0.1% | 0.2% | 0.7% | 5.5% | 6.4% | 1.0% | 2.1% | 0.5% | 2.4% | 0.3% | 0.2% | 1.6% | – | – | – | |
| – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 78.2% | 40.5% | 50.5% | 12.4% | 11.9% | 37.2% | 65.3% | 56.6% | 35.8% | 9.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 590.1% | 10.0% | 7.5% | 6.3% | 7.3% | 15.9% | 6.1% | 5.8% | 41.1% | 52.5% | 643.0% | 652.8% | 33.5% | 55.7% | 7.2% | 15.9% | 7.4% | 3.4% | 7.5% | 5.7% | 12.1% | 8.6% | |
| 590.1% | 10.0% | 7.5% | 6.3% | 7.3% | 15.9% | 6.1% | 5.8% | 41.1% | 52.5% | 643.0% | 478.3% | 33.5% | 55.7% | 7.1% | 14.6% | 7.2% | 3.3% | 6.3% | 5.1% | 11.6% | 8.4% | |
| 77.7% | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 117.5% | 10.7% | 0.0% | 0.0% | 0.7% | 0.2% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | |
| 307.6% | 10.0% | 7.5% | 6.3% | – | – | 0.6% | 2.2% | 29.4% | 12.8% | 340.9% | 303.1% | 13.3% | 28.5% | 2.6% | 2.0% | 3.9% | 1.1% | 2.1% | 1.7% | 2.0% | 2.4% | |
| – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 175.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| -490.1% | 90.0% | 92.5% | 93.7% | 92.7% | 84.1% | 93.9% | 94.2% | 58.9% | 47.5% | -543.0% | -552.8% | 66.5% | 44.3% | 92.8% | 84.1% | 92.6% | 96.6% | 92.5% | 94.3% | 87.9% | 91.4% | |
| -910.7% | -399.9% | -427.2% | -135.8% | -221.7% | -815.6% | -164.2% | -334.9% | -826.5% | -1,277.3% | -13,801.9% | -15,266.7% | -2,493.8% | -2,232.7% | -250.7% | -625.4% | -245.3% | -181.1% | -279.6% | -213.4% | -302.1% | -281.5% | |
| 12,580.8% | 155.7% | 123.9% | 18.5% | 30.3% | 77.1% | 15.8% | 35.7% | 63.6% | 94.0% | 1,103.4% | 1,629.8% | 252.8% | 329.4% | 42.2% | 132.4% | 55.8% | 45.6% | 76.9% | 60.1% | 87.2% | 76.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.